Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression

被引：2
|
作者：
Del Sant, L. C. [1 ]
Magalhaes, E. [1 ]
Lucchese, A. C. [1 ]
Palhares Alves, H. N. [1 ]
Sarin, L. M. [1 ]
Del Porto, J. A. [1 ]
Tavares de lacerda, A. L. [1 ]
机构：
[1] Univ Fed Sao Paulo, Psychiat, Sao Paulo, Brazil
来源：
EUROPEAN PSYCHIATRY | 2017年 / 41卷
关键词：
D O I：
10.1016/j.eurpsy.2017.01.704
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EV0374
引用
收藏
页码：S525 / S526
页数：2
相关论文
共 50 条
  • [41] Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
    James W Murrough
    Katherine E Burdick
    Cara F Levitch
    Andrew M Perez
    Jess W Brallier
    Lee C Chang
    Alexandra Foulkes
    Dennis S Charney
    Sanjay J Mathew
    Dan V Iosifescu
    Neuropsychopharmacology, 2015, 40 : 1084 - 1090
  • [42] Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT
    Allen, A. P.
    Naughton, M.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    McLoughlin, D. M.
    Cryan, J. F.
    Dinan, T. G.
    Clarke, G.
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 186 : 306 - 311
  • [43] Maintenance Ketamine Infusions Demonstrate Sustained Antidepressant Efficacy in a Real-World Treatment-Resistant Unipolar and Bipolar Depression Sample
    Haikazian, Sipan
    Di Vincenzo, Joshua
    Chen-Li, David
    Johnson, Danica
    Mansur, Rodrigo B.
    McIntyre, Roger
    Rosenblat, Joshua
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S210 - S211
  • [44] Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial
    Wilkinson, Samuel T.
    Rhee, Taeho Greg
    Joormann, Jutta
    Webler, Ryan
    Lopez, Mayra Ortiz
    Kitay, Brandon
    Fasula, Madonna
    Elder, Christina
    Fenton, Lisa
    Sanacora, Gerard
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2021, 90 (05) : 318 - 327
  • [45] Intranasal Ketamine in Treatment-resistant Depression
    Lapidus, Kyle A.
    Levitch, Cara F.
    Soleimani, Laili
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S361 - S361
  • [46] Oral ketamine for treatment-resistant depression
    Kang, Seema
    LANCET PSYCHIATRY, 2018, 5 (11): : 877 - 877
  • [47] Esketamine/ketamine for treatment-resistant depression
    Lacerda, Acioly L. T.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (06) : 579 - 580
  • [48] KETAMINE FOR ADOLESCENT TREATMENT-RESISTANT DEPRESSION
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S345 - S345
  • [49] SUBLINGUAL KETAMINE FOR TREATMENT-RESISTANT DEPRESSION
    Hyde, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 154 - 154
  • [50] Gene Expression and Ketamine Response in Subjects With Treatment-Resistant Depression
    Mohazzab-Hosseinian, Sahra
    Kadriu, Bashkim
    Zandi, Peter
    Zarate, Carlos
    Goes, Fernando
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 318 - 319
12345